У нас вы можете посмотреть бесплатно Large-scale cell manufacturing – The CliniMACS Cell Factory® или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
https://www.miltenyibiotec.com/produc... The CliniMACS Cell Factory capitalizes on the automated, closed system cell processing of the CliniMACS Prodigy Platform to reduce cleanroom requirements and enable parallel manufacturing of autologous cell products on multiple instruments - in one room. The CliniMACS Cell Factory is easily scalable, no matter if you are aiming for small-scale local or large-scale centralized manufacturing, our model can be tailored to your vision. In addition to our instruments and expertise we provide MACS® GMP Reagents, Buffers and Media – the single source model helps to reduce regulatory complexities. Overcome the manufacturing challenges. Contact us to find out how the CliniMACS Cell Factory can streamline your processes to realize your goals in cell and gene therapy. Learn more about he CliniMACS Cell Factory and the CliniMACS Prodigy Platform: https://www.miltenyibiotec.com/lp/com... Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company is committed to enable commercial scale cell and gene therapy for the delivery of new treatment options to patients with unmet medical need. The company’s state-of-the-art technologies and products provide integrated workflows for research and clinical applications and have set a new industry standard in automated manufacturing of complex cellular products such as CAR T cells, TCR-transduced T cells, and gene-modified stem cells. Miltenyi Biotec’s portfolio of instruments, reagents and disposables is complemented with contract development and cGMP manufacturing services for lentiviral vectors and cellular products based on the company’s unique platforms for cell processing and cellular analytics. Miltenyi Biotec has more than 2,500 employees in 28 countries and its products have been used in more than 50,000 cell therapy procedures. For more information please visit www.miltenyibiotec.com.